Organon & Co.
OGN
Rang în acțiuni
#4353
Organon & Co., a global pharmaceutical enterprise, is dedicated to developing... Organon & Co., a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments, notably Nexplanon/Implanon, an extended-duration contraceptive. The company's biosimilars collection includes three immune-related medications (Brenzys, Renflexis, Hadlima) and two cancer therapies (Ontruzant, Aybintio). Additionally, Organon provides cardiovascular medications, such as cholesterol-reducing drugs (Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, Zocor) and treatments for high blood pressure (Cozaar, Hyzaar). Their respiratory product line addresses asthma symptoms with brands like Singulair, Dulera, Zenhale, and Asmanex, and manages seasonal allergies through Singulair, Nasonex, Clarinex, and Aerius. Furthermore, their offerings extend to dermatological care (Diprosone, Elocon), bone strengthening (Fosamax), and non-narcotic pain relief (Arcoxia, Diprospan, Celestone). The portfolio also comprises Proscar for treating symptomatic benign prostatic hyperplasia and Propecia for combating male pattern hair loss. The company's products are primarily distributed to pharmaceutical wholesalers, retailers, medical facilities, government entities, and various managed healthcare organizations, including health maintenance organizations and pharmacy benefit managers. Organon & Co. was established in 2020 and is headquartered in Jersey City, New Jersey.
Preț acțiune
$13.76
Ultima sincronizare: 2026-10-16
Capitalizare de piață
$3.61B
Schimbare (1 zi)
-0.04%
Schimbare (1 an)
48.28%
Țară
US
Tranzacționează Organon & Co. (OGN)
Categorie
Healthcare
EPS pentru Organon & Co. (OGN)
EPS la data de June 2026 TTM: $0.79
Conform celor mai recente rapoarte financiare și prețului acțiunilor Organon & Co., EPS-ul actual al companiei (TTM) este $0.79. La sfârșitul anului 2024, compania avea un EPS de $3.36 o scădere comparativ cu EPS-ului din 2023, care a fost de $4.01.
Istoricul EPS pentru Organon & Co. din 2017 până în 2026
EPS la sfârșitul fiecărui an
| An | EPS | Schimbă |
|---|---|---|
| 2026 (TTM) | $0.79 | 9.72% |
| 2025 | $0.72 | -78.57% |
| 2024 | $3.36 | -16.21% |
| 2023 | $4.01 | 11.08% |
| 2022 | $3.61 | -32.27% |
| 2021 | $5.33 | -37.44% |
| 2020 | $8.52 | -32.97% |
| 2019 | $12.71 | 49.35% |
| 2018 | $8.51 | 19.69% |
| 2017 | $7.11 | 0.00% |
EPS pentru companii similare sau concurente
| Companie | EPS | Diferență EPS | Țara |
|---|---|---|---|
| $29.89 | 3,683.54% |
US
|
|
| $6.60 | 735.44% |
US
|
|
| $3.55 | 349.37% |
US
|
|
| $20.39 | 2,480.89% |
CH
|
|
| $1.26 | 59.49% |
US
|
